Loading
institutionsInstitution
Institut Bergonié
Bordeaux's dedicated cancer hospital, a UNICANCER centre known for sarcoma, early-phase trials and precision medicine.
Also called: BergoniéCentre Régional de Lutte Contre le Cancer de Bordeaux
Overview
Founded in 1923 and named after the radiobiologist Jean Bergonié, the Institut Bergonié is the UNICANCER comprehensive cancer centre for Nouvelle-Aquitaine. It is a national reference centre for sarcomas within the French Sarcoma Group and NetSarc network, and runs an early-phase trials unit that is part of INCa's CLIP² network. Research with Université de Bordeaux and Inserm covers sarcoma biology, tumour genomics and radiotherapy. Patients can access phase 1 trials, molecular tumour boards, reconstructive surgery and supportive care on one site.
Location
Bordeaux, FR
Type
cancer center · Université de Bordeaux
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#300 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Institut Bergonié, including child institutions. 410 works · 4,462 citations · 64% open access · 19% clinical trials · 0% reviews.
Oncology works per year
852022
1092023
842024
842025
482026
Most works
- Antoine Italiano83 works
- Sophie Cousin40 works
- Simon Pernot31 works
- Jean‐Philippe Guégan24 works
- Coriolan Lebreton22 works
- Alban Bessede21 works
- François Ghiringhelli18 works
- Christelle Jouannaud18 works
- Florent Peyraud17 works
- Lucile Vanhersecke17 works
Most cited
- Sarcoma reference centre
- Early-phase trials (CLIP²)
- Precision medicine
- Radiotherapy
Antoine Italiano
Head of Early-Phase Trials and Sarcoma Unit, Institut Bergonié, Bordeaux
SarcomaEarly-phase trialsPrecision oncology
Bordeaux oncologist who led CABONE, the trial that showed cabozantinib shrinks or stabilises osteosarcoma and Ewing sarcoma after standard treatment has failed.
Nicolas Penel
Directeur Général (Director General) of Institut Bergonié
Medical oncologySarcomaEarly-phase clinical trials
Medical oncologist and sarcoma specialist who directs Institut Bergonié, the regional cancer centre for Nouvelle-Aquitaine in Bordeaux.
Similar pages
- InstitutionIstanbul University Institute of Oncology
Shares Brachytherapy, Comprehensive genomic profiling, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- InstitutionCentre Oscar Lambret
Shares UNICANCER, Brachytherapy, Sarcomas (soft tissue, bone, GIST), Ovarian cancer.
- PersonAnthony Gonçalves
Shares UNICANCER, Ovarian cancer, HR-positive / HER2-negative breast cancer.
- PersonSuzette Delaloge
Shares Institut National du Cancer, HR-positive / HER2-negative breast cancer.
- InstitutionCentre Léon Bérard
Shares UNICANCER, Rare and paediatric cancers without markets, Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- IdeaOne standing umbrella trial for all rare cancers in a country
Shares UNICANCER, Rare and paediatric cancers without markets, Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- TrialCABONE
Shares Antoine Italiano, Sarcomas (soft tissue, bone, GIST).
- InstitutionNational Institute of Oncology, Hungary
Shares Brachytherapy, Comprehensive genomic profiling, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.